ELEV — Elevation Oncology Share News
0.000.00%
Last trade - 00:00Brief: Elevation Oncology Announces The Promotion Of Valerie Malyvanh Jansen To Chief Medical Officer
Brief: Elevation Oncology Inc Seribantumab Included As Part Of A Case Series Presentation At The Australasian Gastro-Intestinal Trials Group 2021 Annual Scientific Meeting
Brief: Elevation Oncology Reports Second Quarter 2021 Financial Results
Elevation Oncology Inc reports results for the quarter ended in June - Earnings Summary
NASDAQ RESUMED AT 09:36 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:33 AM
NASDAQ RESUMED AT 01:09 PM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 04:00 AM
Brief: Elevation Oncology Announces Pricing Of Initial Public Offering